Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

NFL icon Brett Favre, diagnosed with Parkinson's in September 2024, is exploring unconventional treatments. He's undergoing ...

And he had a subtle but persistent tremor – a shakiness in his hands that was hard to explain. But Mel reassured herself with ...

In a significant leap forward for successful cancer surgery, researchers at the University of Missouri and collaborators have ...

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

A novel consent process facilitated the prospective use of real-world data to evaluate clinical changes without the delays ...

With the ever-increasing potential of new technology and the exponential growth of the life sciences field, researchers are ...

| AI solutions in clinical trials are only as good as the data they process. With a focus on quality, AI can be harnessed to ...

US biotech fund BVF Parners has sold its stake in drug developer Syntara, thus exiting all of its ASX life sciences exposures ...